Patrícia Paiva Corsetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Patrícia Paiva Corsetti has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Leonardo Augusto de Almeida
Laboratory of Molecular Biology of Microorganisms, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil
8 shared publications - Evandro Neves Silva
Laboratory of Molecular Biology of Microorganisms, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil
5 shared publications - Leonardo Pereira de Araújo
Laboratory of Molecular Biology of Microorganisms, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil
3 shared publications - José Antonio Dias Garcia
Universidade José do Rosário Vellano
2 shared publications - Maria das Graças de Souza Carvalho
Universidade Estadual de Campinas
2 shared publications Thaís Cristina Ferreira dos Santos
Laboratory of Molecular Biology of Microorganisms, Federal University of Alfenas (UNIFAL-MG), Alfenas, Minas Gerais, Brazil; Professor Edson Antonio Velano University (UNIFENAS), Alfenas, Minas Gerais, Brazil
2 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 440, 112396
Integrative network pharmacology and experimental evaluation reveal TNBC-related biological activity and toxicity of Euphorbia umbellata crude latex
- 23 October 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 440, 112396
Open AccessIntegrative network pharmacology and experimental evaluation reveal TNBC-related biological activity and toxicity of Euphorbia umbellata crude latex
- 15 April 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 204, 107594
Amoxicillin-induced bacterial gut dysbiosis: A critical influence on mice reproduction and their offspring development
- 15 April 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 204, 107594
Amoxicillin-induced bacterial gut dysbiosis: A critical influence on mice reproduction and their offspring development
- 19 February 2025
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 56 (2) , 1083-1094
Sequential macrophage DENV and ZIKV infection shows differential expression of CD86, IFN-β, and regulation of TNF-α and IL-1β depending on DENV serotype
Dengue virus (DENV) is an RNA virus belonging to the Flaviviridae family, comprising four antigenically distinct serotypes. Dengue is the primary arthropod-transmitted virus globally, posing a significant public health challenge, especially in Brazil, where the largest outbreak of Zika virus (ZIKV) was also recorded in 2016. ZIKV shares genomic and structural similarities with DENV, and their co-circulation in Brazil provides evidence of co-infection. The innate immune response against DENV and ZIKV is mediated by pattern recognition receptors that initiate intracellular signaling, leading to antiviral or inflammatory responses. This study aims to better understand the innate immune response to ZIKV in macrophages previously infected with DENV. To achieve this, bone marrow cells from C57BL/6 mice were differentiated into macrophages (BMDMs) and independently infected with each of the four DENV serotypes for 12 h, followed by ZIKV infection for an additional 12 h. Twenty-four hours post-infection, macrophage activation markers CD86 were assessed using flow cytometry and fluorescence microscopy. Pro-inflammatory and antiviral gene expressions were evaluated by qPCR. IFN-β was found to be down-regulated in all analyzed groups. No differences in CD86 expression were observed in ZIKV-infected BMDMs previously infected with DENV, except for serotype 4, which showed an increase in both activation markers. Conversely, TNF-α and IL-1β were down-regulated compared to non-infected or only DENV4-infected cells, correlating with increased cell viability and decreased production of the cytokine TNF-α. Bioinformatic analysis suggested that the expression of both cytokines might be regulated by miRNAs, including miR-181a-5p, which is also up-regulated in the innate immune response. Taken together, the results indicated that co-infection with DENV serotype 4 and ZIKV in mice BMDMs increases the expression of CD86, promoting macrophage activation, but reduces the expression of pro-inflammatory genes TNF-α and IL-1β, indicating enhanced cell viability what can be modulated by miRNAs.
- 19 February 2025
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 56 (2) , 1083-1094
Sequential macrophage DENV and ZIKV infection shows differential expression of CD86, IFN-β, and regulation of TNF-α and IL-1β depending on DENV serotype
Dengue virus (DENV) is an RNA virus belonging to the Flaviviridae family, comprising four antigenically distinct serotypes. Dengue is the primary arthropod-transmitted virus globally, posing a significant public health challenge, especially in Brazil, where the largest outbreak of Zika virus (ZIKV) was also recorded in 2016. ZIKV shares genomic and structural similarities with DENV, and their co-circulation in Brazil provides evidence of co-infection. The innate immune response against DENV and ZIKV is mediated by pattern recognition receptors that initiate intracellular signaling, leading to antiviral or inflammatory responses. This study aims to better understand the innate immune response to ZIKV in macrophages previously infected with DENV. To achieve this, bone marrow cells from C57BL/6 mice were differentiated into macrophages (BMDMs) and independently infected with each of the four DENV serotypes for 12 h, followed by ZIKV infection for an additional 12 h. Twenty-four hours post-infection, macrophage activation markers CD86 were assessed using flow cytometry and fluorescence microscopy. Pro-inflammatory and antiviral gene expressions were evaluated by qPCR. IFN-β was found to be down-regulated in all analyzed groups. No differences in CD86 expression were observed in ZIKV-infected BMDMs previously infected with DENV, except for serotype 4, which showed an increase in both activation markers. Conversely, TNF-α and IL-1β were down-regulated compared to non-infected or only DENV4-infected cells, correlating with increased cell viability and decreased production of the cytokine TNF-α. Bioinformatic analysis suggested that the expression of both cytokines might be regulated by miRNAs, including miR-181a-5p, which is also up-regulated in the innate immune response. Taken together, the results indicated that co-infection with DENV serotype 4 and ZIKV in mice BMDMs increases the expression of CD86, promoting macrophage activation, but reduces the expression of pro-inflammatory genes TNF-α and IL-1β, indicating enhanced cell viability what can be modulated by miRNAs.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 68, e25250060
What is the Best Option for Cellular Immunotherapies in Triple-Negative Breast Cancer? A Systematic Review Based on in vitro and in vivo Evidences
Triple-negative breast cancer (TNBC) is the breast cancer subtype with the worst prognosis and highest malignancy. As an alternative treatment, immunotherapy has gained prominence in recent years for its use of components that modulate the patient's own immune system to combat cancer. Although approved therapies using monoclonal antibodies have shown limitations, a more promising alternative for TNBC is the use of immune cells, which have the ability to infiltrate solid tumors and remain in the tumor microenvironment long-term, promoting a localized and effective immune response. The present study proposed a systematic review of cellular immunotherapies currently under investigation for TNBC. The review was registered with PROSPERO (CRD42024591409). Studies were selected using the PRISMA strategy, and the risk of bias in in vivo studies was assessed with the SYRCLE tool. A total of six studies with in vitro and in vivo analyses were included. Among these, 50% evaluated CAR-T therapy (Chimeric Antigen Receptor T Cells), 16.6% CAR-M therapy (Chimeric Antigen Receptor Macrophages), 16.6% dendritic cell vaccines, and 16.6% autologous CD4+ T lymphocytes stimulated ex vivo. The in vitro analyses focused on antitumor capacity, cell proliferation, cytokine production, apoptosis, and phagocytosis. For the in vivo analyses, tumor growth, survival, metastasis development, and cellular infiltration were evaluated. All therapies demonstrated promising effects; notably, immunotherapy with autologous CD4+ T lymphocytes achieved the greatest tumor reduction among the studied therapies. This review highlights the potential of immune cell-based therapies, particularly CD4+ T lymphocytes, emphasizing the need for further research and potential human testing.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 68, e25250060
Open AccessWhat is the Best Option for Cellular Immunotherapies in Triple-Negative Breast Cancer? A Systematic Review Based on in vitro and in vivo Evidences
Triple-negative breast cancer (TNBC) is the breast cancer subtype with the worst prognosis and highest malignancy. As an alternative treatment, immunotherapy has gained prominence in recent years for its use of components that modulate the patient's own immune system to combat cancer. Although approved therapies using monoclonal antibodies have shown limitations, a more promising alternative for TNBC is the use of immune cells, which have the ability to infiltrate solid tumors and remain in the tumor microenvironment long-term, promoting a localized and effective immune response. The present study proposed a systematic review of cellular immunotherapies currently under investigation for TNBC. The review was registered with PROSPERO (CRD42024591409). Studies were selected using the PRISMA strategy, and the risk of bias in in vivo studies was assessed with the SYRCLE tool. A total of six studies with in vitro and in vivo analyses were included. Among these, 50% evaluated CAR-T therapy (Chimeric Antigen Receptor T Cells), 16.6% CAR-M therapy (Chimeric Antigen Receptor Macrophages), 16.6% dendritic cell vaccines, and 16.6% autologous CD4+ T lymphocytes stimulated ex vivo. The in vitro analyses focused on antitumor capacity, cell proliferation, cytokine production, apoptosis, and phagocytosis. For the in vivo analyses, tumor growth, survival, metastasis development, and cellular infiltration were evaluated. All therapies demonstrated promising effects; notably, immunotherapy with autologous CD4+ T lymphocytes achieved the greatest tumor reduction among the studied therapies. This review highlights the potential of immune cell-based therapies, particularly CD4+ T lymphocytes, emphasizing the need for further research and potential human testing.
- Open Access
- 7 October 2023
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 229 (Supplement) , S285-S292
Immunoinformatic Approach for Rational Identification of Immunogenic Peptides Against Host Entry and/or Exit Mpox Proteins and Potential Multiepitope Vaccine Construction
COVID-19 has intensified humanity's concern about the emergence of new pandemics. Since 2018, epidemic outbreaks of the mpox virus have become worrisome. In June 2022, the World Health Organization declared the disease a global health emergency, with 14 500 cases reported by the Centers for Disease Control and Prevention in 60 countries. Therefore, the development of a vaccine based on the current virus genome is paramount in combating new cases. In view of this, we hypothesized the obtainment of rational immunogenic peptides predicted from proteins responsible for entry of the mpox virus into the host (A17L, A26L/A30L, A33R, H2R, L1R), exit (A27L, A35R, A36R, C19L), and both (B5R). To achieve this, we aligned the genome sequencing data of mpox virus isolated from an infected individual in the United States in June 2022 (ON674051.1) with the reference genome dated 2001 (NC_003310.1) for conservation analysis. The Immune Epitope Database server was used for the identification and characterization of the epitopes of each protein related to major histocompatibility complex I or II interaction and recognition by B-cell receptors, resulting in 138 epitopes for A17L, 233 for A28L, 48 for A33R, 77 for H2R, 77 for L1R, 270 for A27L, 72 for A35R, A36R, 148 for C19L, and 276 for B5R. These epitopes were tested in silico for antigenicity, physicochemical properties, and allergenicity, resulting in 51, 40, 10, 34, 38, 57, 25, 7, 47, and 53 epitopes, respectively. Additionally, to select an epitope with the highest promiscuity of binding to major histocompatibility complexes and B-cell receptor simultaneously, all epitopes of each protein were aligned, and the most repetitive and antigenic regions were identified. By classifying the results, we obtained 23 epitopes from the entry proteins, 16 from the exit proteins, and 7 from both. Subsequently, 1 epitope from each protein was selected, and all 3 were fused to construct a chimeric protein that has potential as a multiepitope vaccine. The constructed vaccine was then analyzed for its physicochemical, antigenic, and allergenic properties. Protein modeling, molecular dynamics, and molecular docking were performed on Toll-like receptors 2, 4, and 8, followed by in silico immune simulation of the vaccine. Finally, the results indicate an effective, stable, and safe vaccine that can be further tested, especially in vitro and in vivo, to validate the findings demonstrated in silico.
- 7 October 2023
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 229 (Supplement) , S285-S292
Open AccessImmunoinformatic Approach for Rational Identification of Immunogenic Peptides Against Host Entry and/or Exit Mpox Proteins and Potential Multiepitope Vaccine Construction
COVID-19 has intensified humanity's concern about the emergence of new pandemics. Since 2018, epidemic outbreaks of the mpox virus have become worrisome. In June 2022, the World Health Organization declared the disease a global health emergency, with 14 500 cases reported by the Centers for Disease Control and Prevention in 60 countries. Therefore, the development of a vaccine based on the current virus genome is paramount in combating new cases. In view of this, we hypothesized the obtainment of rational immunogenic peptides predicted from proteins responsible for entry of the mpox virus into the host (A17L, A26L/A30L, A33R, H2R, L1R), exit (A27L, A35R, A36R, C19L), and both (B5R). To achieve this, we aligned the genome sequencing data of mpox virus isolated from an infected individual in the United States in June 2022 (ON674051.1) with the reference genome dated 2001 (NC_003310.1) for conservation analysis. The Immune Epitope Database server was used for the identification and characterization of the epitopes of each protein related to major histocompatibility complex I or II interaction and recognition by B-cell receptors, resulting in 138 epitopes for A17L, 233 for A28L, 48 for A33R, 77 for H2R, 77 for L1R, 270 for A27L, 72 for A35R, A36R, 148 for C19L, and 276 for B5R. These epitopes were tested in silico for antigenicity, physicochemical properties, and allergenicity, resulting in 51, 40, 10, 34, 38, 57, 25, 7, 47, and 53 epitopes, respectively. Additionally, to select an epitope with the highest promiscuity of binding to major histocompatibility complexes and B-cell receptor simultaneously, all epitopes of each protein were aligned, and the most repetitive and antigenic regions were identified. By classifying the results, we obtained 23 epitopes from the entry proteins, 16 from the exit proteins, and 7 from both. Subsequently, 1 epitope from each protein was selected, and all 3 were fused to construct a chimeric protein that has potential as a multiepitope vaccine. The constructed vaccine was then analyzed for its physicochemical, antigenic, and allergenic properties. Protein modeling, molecular dynamics, and molecular docking were performed on Toll-like receptors 2, 4, and 8, followed by in silico immune simulation of the vaccine. Finally, the results indicate an effective, stable, and safe vaccine that can be further tested, especially in vitro and in vivo, to validate the findings demonstrated in silico.
- Open Access
- 21 December 2021
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 778475
Epitope-Based Vaccine of a Brucella abortus Putative Small RNA Target Induces Protection and Less Tissue Damage in Mice
Brucellaspp. are Gram-negative, facultative intracellular bacteria that cause brucellosis in humans and animals. Currently available live attenuated vaccines against brucellosis still have drawbacks. Therefore, subunit vaccines, produced using epitope-based antigens, have the advantage of being safe, cost-effective and efficacious. Here, we identifiedB. abortussmall RNAs expressed during early infection with bone marrow-derived macrophages (BMDMs) and an apolipoprotein N-acyltransferase (Int) was identified as the putative target of the greatest expressed small RNA. Decreased expression of Int was observed during BMDM infection and the protein sequence was evaluated to rationally select a putative immunogenic epitope by immunoinformatic, which was explored as a vaccinal candidate. C57BL/6 mice were immunized and challenged withB. abortus, showing lower recovery in the number of viable bacteria in the liver, spleen, and axillary lymph node and greater production of IgG and fractions when compared to non-vaccinated mice. The vaccinated and infected mice showed the increased expression ofTNF-α,IFN-γ, and IL-6 following expression of the anti-inflammatory genesIL-10andTGF-βin the liver, justifying the reduction in the number and size of the observed granulomas. BMDMs stimulated with splenocyte supernatants from vaccinated and infected mice increase the CD86+ marker, as well as expressing greater amounts of iNOS and the consequent increase in NO production, suggesting an increase in the phagocytic and microbicidal capacity of these cells to eliminate the bacteria.
- 21 December 2021
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 778475
Open AccessEpitope-Based Vaccine of a Brucella abortus Putative Small RNA Target Induces Protection and Less Tissue Damage in Mice
Brucellaspp. are Gram-negative, facultative intracellular bacteria that cause brucellosis in humans and animals. Currently available live attenuated vaccines against brucellosis still have drawbacks. Therefore, subunit vaccines, produced using epitope-based antigens, have the advantage of being safe, cost-effective and efficacious. Here, we identifiedB. abortussmall RNAs expressed during early infection with bone marrow-derived macrophages (BMDMs) and an apolipoprotein N-acyltransferase (Int) was identified as the putative target of the greatest expressed small RNA. Decreased expression of Int was observed during BMDM infection and the protein sequence was evaluated to rationally select a putative immunogenic epitope by immunoinformatic, which was explored as a vaccinal candidate. C57BL/6 mice were immunized and challenged withB. abortus, showing lower recovery in the number of viable bacteria in the liver, spleen, and axillary lymph node and greater production of IgG and fractions when compared to non-vaccinated mice. The vaccinated and infected mice showed the increased expression ofTNF-α,IFN-γ, and IL-6 following expression of the anti-inflammatory genesIL-10andTGF-βin the liver, justifying the reduction in the number and size of the observed granulomas. BMDMs stimulated with splenocyte supernatants from vaccinated and infected mice increase the CD86+ marker, as well as expressing greater amounts of iNOS and the consequent increase in NO production, suggesting an increase in the phagocytic and microbicidal capacity of these cells to eliminate the bacteria.
- Open Access
- 2 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (13)
Dyslipidemia’s influence on the secretion ovarian’s steroids in female mice
Introduction: The synthesis ovarian’s steroids is a process thats depends on the supply of cholesterol. Objective: to evaluate the influence of dyslipidemia on the secretion ovarian’s steroids. Methodology: wild female mice were used (C57BL6) and LDL (LDLR-/-), which they were separated into 4 groups (n = 10): WTS: fed a standard diet; WTHL: fed a high-fat diet; KOS: fed a standard diet; KOHL: fed a high-fat diet. After 60 days, the estrous cycle was analyzed and after anesthetized, blood was collected for the to assess the lipid profile, glucose, plasma insulin level and HOMA index was calculated. In addition, plasma levels of C-reactive protein, estrogen and progesterone were determined. Results: The hyperlipidic diet in both the WTHL and the KOHL group generated hypercholesterolemia when compared to the WTS and KOS, respectively, with a decrease in HDLc, associated with an increase in CRP levels. Severe hypercholesterolemia in the KOHL group generated insulin resistance, marked by an increase in HOMAir. Food hypercholesterolemia in the WTHL group, food and genetics in the KOHL group, compared to their WTS and KOS controls, was definitive in reducing plasma levels of estrogen and progesterone. The genetic hypercholesterolemia associated with insulin resistance observed in the KOS and KOHL groups reduced the levels of progesterone, this reduction being more severe in the KOHL group, which had the highest HOMAir. Conclusion: dyslipidemia affected ovarian steroidogenesis in mice by means of oxidative stress, inflammation and insulin resistance and / or by decreasing HDL cholesterol levels.
- 2 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (13)
Open AccessDyslipidemia’s influence on the secretion ovarian’s steroids in female mice
Introduction: The synthesis ovarian’s steroids is a process thats depends on the supply of cholesterol. Objective: to evaluate the influence of dyslipidemia on the secretion ovarian’s steroids. Methodology: wild female mice were used (C57BL6) and LDL (LDLR-/-), which they were separated into 4 groups (n = 10): WTS: fed a standard diet; WTHL: fed a high-fat diet; KOS: fed a standard diet; KOHL: fed a high-fat diet. After 60 days, the estrous cycle was analyzed and after anesthetized, blood was collected for the to assess the lipid profile, glucose, plasma insulin level and HOMA index was calculated. In addition, plasma levels of C-reactive protein, estrogen and progesterone were determined. Results: The hyperlipidic diet in both the WTHL and the KOHL group generated hypercholesterolemia when compared to the WTS and KOS, respectively, with a decrease in HDLc, associated with an increase in CRP levels. Severe hypercholesterolemia in the KOHL group generated insulin resistance, marked by an increase in HOMAir. Food hypercholesterolemia in the WTHL group, food and genetics in the KOHL group, compared to their WTS and KOS controls, was definitive in reducing plasma levels of estrogen and progesterone. The genetic hypercholesterolemia associated with insulin resistance observed in the KOS and KOHL groups reduced the levels of progesterone, this reduction being more severe in the KOHL group, which had the highest HOMAir. Conclusion: dyslipidemia affected ovarian steroidogenesis in mice by means of oxidative stress, inflammation and insulin resistance and / or by decreasing HDL cholesterol levels.
- Open Access
- 1 August 2020
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 72 (4) , 1286-1294
Efeito do extrato de Bidens pilosa L., Mel e pomadas homeopática e alopática na cicatrização de feridas cutâneas de ratos Wistar
RESUMO Cicatrização de ferida é um processo dinâmico, que tem por objetivo restaurar a continuidade do tecido lesionado. No entanto, em alguns casos, é necessário favorecer condições adequadas para viabilizar o processo fisiológico. Neste estudo foram utilizados ratos Wistar, divididos aleatoriamente entre cinco grupos, com 12 animais cada, sendo eles: grupo P (Bidens pilosa L.), grupo mel, grupo Co1 (pomada comercial alopática), grupo Co2 (pomada comercial homeopática) e grupo CT (controle). As lesões foram geradas por incisão com punch de 8mm, sendo tratadas diariamente de forma tópica. Foram eutanasiados quatro animais por grupo, no terceiro, sétimo e 14º dias do experimento, e o material coletado foi armazenado em formalina 10% e encaminhado para processamento histológico. Posteriormente, realizou-se a contagem de leucócitos mononucleares, fibroblastos e neovasos e avaliou-se a arquitetura de fibras colágenas. Os resultados da contagem foram analisados pela ANOVA, seguida pelo teste de Tukey (P<0,05). O modelo experimental proposto neste estudo demonstrou que todos os tratamentos apresentaram potencial cicatrizante, com exceção do mel. A aplicação tópica do creme do extrato de Bidens pilosa L. a 10% apresentou melhor perfil anti-inflamatório; a pomada alopática apresentou boa aderência à superfície da lesão e a pomada homeopática, grande potencial angiogênico, com menor tempo de cicatrização.
- 1 August 2020
- Published by FapUNIFESP (SciELO) in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
- Vol. 72 (4) , 1286-1294
Open AccessEfeito do extrato de Bidens pilosa L., Mel e pomadas homeopática e alopática na cicatrização de feridas cutâneas de ratos Wistar
RESUMO Cicatrização de ferida é um processo dinâmico, que tem por objetivo restaurar a continuidade do tecido lesionado. No entanto, em alguns casos, é necessário favorecer condições adequadas para viabilizar o processo fisiológico. Neste estudo foram utilizados ratos Wistar, divididos aleatoriamente entre cinco grupos, com 12 animais cada, sendo eles: grupo P (Bidens pilosa L.), grupo mel, grupo Co1 (pomada comercial alopática), grupo Co2 (pomada comercial homeopática) e grupo CT (controle). As lesões foram geradas por incisão com punch de 8mm, sendo tratadas diariamente de forma tópica. Foram eutanasiados quatro animais por grupo, no terceiro, sétimo e 14º dias do experimento, e o material coletado foi armazenado em formalina 10% e encaminhado para processamento histológico. Posteriormente, realizou-se a contagem de leucócitos mononucleares, fibroblastos e neovasos e avaliou-se a arquitetura de fibras colágenas. Os resultados da contagem foram analisados pela ANOVA, seguida pelo teste de Tukey (P<0,05). O modelo experimental proposto neste estudo demonstrou que todos os tratamentos apresentaram potencial cicatrizante, com exceção do mel. A aplicação tópica do creme do extrato de Bidens pilosa L. a 10% apresentou melhor perfil anti-inflamatório; a pomada alopática apresentou boa aderência à superfície da lesão e a pomada homeopática, grande potencial angiogênico, com menor tempo de cicatrização.
- 18 April 2020
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 84 (1) , e13247
Amoxicillin‐induced gut dysbiosis influences estrous cycle in mice and cytokine expression in the ovary and the caecum
Problem: Gut dysbiosis is caused by several factors, including the use of antibiotics. Since intestinal dysbiosis is associated with a wide range of immunopathological and reproductive conditions, the main goal of this study was to evaluate amoxicillin‐induced gut dysbiosis and its influence on the oestrous cycle in mice.Method of study: Mice were treated with amoxicillin or PBS, and faecal microbiota was evaluated by 16S rDNA metagenomic sequencing. The oestrous cycle was evaluated by vaginal cytology, vaginal opening and flow cytometry. After the induction of gut dysbiosis, the ovaries and the caecum were analysed to differential expression of IL‐1β and IL‐10 genes and histological analysis.Results: Amoxicillin‐treated mice presented differing bacterial groups in the faecal microbiota when compared to the PBS‐treated group indicating that amoxicillin treatment‐induced gut dysbiosis and they gained weight. The vaginal cytology analysis showed that amoxicillin‐induced gut dysbiosis decreased the number of cells but increased the relative number of leucocytes and altered the oestrous cycle. IL‐1β was shown to be upregulated in the caecum and in the ovary of the dysbiotic mice. On the other hand, IL‐10 expression was shown to be diminished in both organs of the dysbiotic mice. The oocyte area from dysbiotic group presented lower than non‐dysbiotic mice with increasing thickness of the pellucid zone. The follicular teak from dysbiotic mice showed lower thickness than non‐dysbiotic mice.Conclusion: The results indicate that amoxicillin induces gut dysbiosis and influences the oestrous cycle and the inflammatory status of the ovary and the caecum.
- 18 April 2020
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 84 (1) , e13247
Amoxicillin‐induced gut dysbiosis influences estrous cycle in mice and cytokine expression in the ovary and the caecum
Problem: Gut dysbiosis is caused by several factors, including the use of antibiotics. Since intestinal dysbiosis is associated with a wide range of immunopathological and reproductive conditions, the main goal of this study was to evaluate amoxicillin‐induced gut dysbiosis and its influence on the oestrous cycle in mice.Method of study: Mice were treated with amoxicillin or PBS, and faecal microbiota was evaluated by 16S rDNA metagenomic sequencing. The oestrous cycle was evaluated by vaginal cytology, vaginal opening and flow cytometry. After the induction of gut dysbiosis, the ovaries and the caecum were analysed to differential expression of IL‐1β and IL‐10 genes and histological analysis.Results: Amoxicillin‐treated mice presented differing bacterial groups in the faecal microbiota when compared to the PBS‐treated group indicating that amoxicillin treatment‐induced gut dysbiosis and they gained weight. The vaginal cytology analysis showed that amoxicillin‐induced gut dysbiosis decreased the number of cells but increased the relative number of leucocytes and altered the oestrous cycle. IL‐1β was shown to be upregulated in the caecum and in the ovary of the dysbiotic mice. On the other hand, IL‐10 expression was shown to be diminished in both organs of the dysbiotic mice. The oocyte area from dysbiotic group presented lower than non‐dysbiotic mice with increasing thickness of the pellucid zone. The follicular teak from dysbiotic mice showed lower thickness than non‐dysbiotic mice.Conclusion: The results indicate that amoxicillin induces gut dysbiosis and influences the oestrous cycle and the inflammatory status of the ovary and the caecum.